(Q41460565)

1 October 2017

1 reference

title

Vanishing bile duct syndrome in drug-induced liver disease (English)

1 reference

Vanishing bile duct syndrome

1 October 2017

main subject

1 reference

V J Desmet

1

1 reference

1 October 2017

publication date

1 January 1997

1 reference

1 October 2017

published in

Journal of Hepatology

1 reference

1 October 2017

volume

26 Suppl 1

1 reference

1 October 2017

page(s)

31-35

1 reference

Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Drug-induced cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Primary biliary cirrhosis after long-term practolol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Tetracycline-induced bile duct paucity and prolonged cholestasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

A case of drug-induced ductopenia resulting in fatal biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Criteria of drug-induced liver disorders. Report of an international consensus meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Chronic chlorpromazine jaundice: with particular reference to its relationship to primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Cytokeratins and the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Liver damage from flucloxacillin, cloxacillin and dicloxacillin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Three-dimensional reconstruction of biliary pathways in primary biliary cirrhosis: a computer-assisted study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Drug-induced cholestasis: pathogenesis and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

An industrial outbreak of toxic hepatitis due to methylenedianiline

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Hepatic injury in the toxic epidemic syndrome caused by ingestion of adulterated cooking oil (Spain, 1981)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Hepatic injury associated with paraquat toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Mouse strain differences in susceptibility to sporidesmin-induced biliary tract injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Protection by antibiotics against experimental focal cholangitis produced in mice by a schistosomicidal isothiocyanate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Sclerosing cholangitis after continuous hepatic artery infusion of FUDR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Causes of jaundice during hepatic artery infusion chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

A new look at the arterial supply of the bile duct in man and its surgical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

Caustic sclerosing cholangitis. A complication of the surgical treatment of hydatid disease of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

New concepts in biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2982330-6

7 January 2021

10.1016/S0168-8278(97)82330-6

Identifiers

DOI

1 reference

1 October 2017

1 reference